An institutional policy for consult agreements developed pursuant to division (C) of section 4729.39 of the Revised Code must include at least the following criteria:
(A) The appropriate institutional credentialing or privileging procedures for each individual pharmacist prior to the pharmacist acting under any consult agreement;
(B) The credentialing or privileging procedures that delineate an individual pharmacist’s scope of privileges when acting under a consult agreement;
(C) An appropriate quality assurance mechanism to ensure that pharmacists who act under a consult agreement do so only within the scope of privileges granted;
(D) A written description for each of the following:
(1) The mechanism to be used for coverage when the consult agreement pharmacist or physician is not physically present;
(2) How the consult agreement will be made in writing;
(3) How the consult agreement shall be communicated to the patient or legal guardian;
(4) How the pharmacist shall document each action taken under the consult agreement;
(5) The methods to be used for the required communication between a pharmacist and physician;
(6) The appropriate methods for terminating a consult agreement.
R.C. 119.032 review dates: 09/26/2008 and 09/26/2013
Promulgated Under: 119.03
Statutory Authority: 4729.26
Rule Amplifies: 4729.39
Prior Effective Dates: 6/1/2001